References
- Huang M., Ye Y., Chen S. Use of all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567
- Castaigne W., Chomienne C., Daniel M.T. All trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia I. Clinical results. Blood 1990; 76: 1704
- Warrell R.P., Jr., Frankel S.R., Miller W.H., Jr. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 1991; 324: 1385
- Warrell R.P., Jr. All-trans-retinoic acid: What is it good for?. J Clin. Oncol. 1992; 10(11)1659
- Fenauz P., Castaigne S., Droubet H. All trans-retinoic acid in new diagnosed acute promyelocytic leukemia: A pilot study. Blood, 78: 79A, (suppl)
- Frankel S.R., Eardley A. The retinoic acid syndrome in acute promyelocytic leukemia. Ann. Intern. Med. 1992; 117: 292
- Muindi J., Frankel S.R., Miller W.H., Jr., Jakubowski A., Scheinberg D.A., Young C.W., Dmitrovsky E., Warrell R.P., Jr. Continuous treatment with all-trans-retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood 1992; 79(2)299
- Smith M.A., Adamson P.C., Balis F.M. Phase I and pharmacokinetic evaluation of all-trans retinoic acid in perdatric patient. J. Clin. Oncol. 1992; 10: 1666
- Frankel S.R. All-trans-retinoic acid in APL. Contemporary Oncol 1992; 36
- Lautersztain J., Perez-Soler R., Turpin J., Khokhar A.R., Siddik Z.H., Schmidt K., Lopez-Berestein G. Cellular pharmacology of liposomal entrapped cis-bis-neodecanoato-trans-R,R-1,2-diamino cyclohexane platinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes. Cancer Res. 1988; 48: 1300
- Mehta K., Lopez-Berestein G., Hersh E.M., Juliano R.L. Uptake of liposome and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes. J. Reticuloendoth. Soc. 1982; 32: 155
- Lopez-Berestein G., Kasi L., Rosenblum M.G., Haynie T., Jahns M., Glenn H., Mehta R., Mavligit G.M., Hersh E.M. Clinical pharmacology of 99mTc-labeled lipsomes in patients with cancer. Cancer Res. 1984; 44: 375
- Perez-Soler R., Lopez-Berestein G., Kasi L., Cabanillas F., Jahns M., Glenn H., Haynie T.P., Hersh E.M. Distribution of 99mTc labeled liposomes in patients with Hodgkin disease. J. Nucl. Med. 1985; 26: 743
- Perez-Soler R., Lopez-Berestein G., Lautersztain J., Al-Baker S., Francis K., Macias-Kiger D., Raber M.N., Khokhar A.R. Phase I clinical and pharmacologic study of liposome entrapped cis-bis-neodecanoato-trans-rr-1,2-diamino cyclohexane platinum (II). Cancer Res. 1990; 50: 4254
- Lopez-Berestein G., Bodey G.P., Frankel L.S., Mehta K. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. J. Clin. Oncol. 1987; 5(2)310
- Drach J., Lopez-Berestein G., McQueen T., Andreeff M., Mehta K. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-frans-retinoic acid. Cancer Res. 1993; 53: 2100–2104
- Sacks P., Oke V., Mehta K. Antiproliferative effects of free and liposome-encapsulated retinoic acid in a squamous carcinoma model: monolayer cells and multicellular tumor spheroids. J. Cancer Res. Clin. Oncol. 1992; 118: 490
- Eriksson U. Extra and intracellular transport of retinoids. Subcellular Biochemistry, vol 16, H. J. Hilderson. Plenum Press, New York 1990